MedPath

A study on improving bone health in female epileptic patients

Not Applicable
Conditions
Health Condition 1: null- Female epileptic patients
Registration Number
CTRI/2015/08/006103
Lead Sponsor
KG Hospital and Postgraduate Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

•Female patients diagnosed with epilepsy and under anti-epileptic drug therapy for at least a period of two years

•The patient aged 15 to 45

•Patients with same characteristics both physically as well as clinically

•Both in-patients and out-patients of department of Neurology.

•The patients who are keeping up their regular follow-up appointments.

•The patient who are willing to give informed content.

Exclusion Criteria

•Pre-pubertic girls and postmenopausal women.

•Patients with conditions known to affect bone metabolism such as hepatic or renal disorders, hypothyroidism, or malabsorption.

•Patients with a history of intake of pharmacologic amounts of medications that can affect bone turn over (e.g., Vitamin A, anabolic steroids, bisphosphonates, glucocorticoids, thiazides, calcitonin)

•Patients from pediatrics, pregnant women, gynecological patients with hormone imbalance and emergency

•Psychiatric patients

•Patients not coming for regular follow up

•Patients who are not willing to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improved Bone mineral densityTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Decreased Fracture RiskTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath